Choroidal Abnormalities in Pediatric NF1: A Cohort Natural History Study.
NF1
choroidal abnormalities
neurofibromatosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Mar 2022
10 Mar 2022
Historique:
received:
19
02
2022
revised:
01
03
2022
accepted:
09
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
The purpose of this study was to assess the long-term natural history of choroidal abnormalities (CAs) in a large pediatric neurofibromatosis type 1 (NF1) population, quantifying their progression in number and dimensions. Pediatric patients (<16 years old) affected by NF1 with a minimum follow-up of 3 years with at least one CA in one eye were consecutively recruited. Near-infrared (NIR) imaging was performed to identify CAs, which were quantified in number and size. The CAs area and perimeter were normalized for the optic disc dimensions to avoid possible bias related to the growing process of the eye. Ninety-nine eyes of 53 patients were evaluated. The CAs number, area and perimeter significantly increased during follow-up (p < 0.0001 for each parameter). The patient age at baseline was inversely correlated with the CAs number over time (coefficient = −0.1313, p = 0.0068), while no correlation was found between the patient age and CAs progression in size. In conclusion, we provide evidence that, in NF1 pediatric patients, CAs change over time, increasing both in number and dimensions, independently from the physiological growth of the eye. While the increase of the CAs number occurs particularly at an earlier age, the increase in the CAs dimensions is a slow process that remains constant during childhood.
Identifiants
pubmed: 35326581
pii: cancers14061423
doi: 10.3390/cancers14061423
pmc: PMC8946817
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Med Genet A. 2010 Feb;152A(2):327-32
pubmed: 20082463
Clin Ophthalmol. 2012;6:1191-4
pubmed: 22888215
Ophthalmology. 2012 Feb;119(2):369-75
pubmed: 21963267
Ophthalmic Genet. 2021 Jun;42(3):223-229
pubmed: 33594930
Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):307-311
pubmed: 29290016
J Med Genet. 2003 Oct;40(10):e109
pubmed: 14569132
Am J Ophthalmol. 1985 Mar 15;99(3):367-8
pubmed: 3919589
J Optom. 2020 Apr - Jun;13(2):128-136
pubmed: 31992535
Acta Ophthalmol. 2015 Dec;93(8):e667-71
pubmed: 25990002
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):775
pubmed: 26934132
Ann Neurol. 2007 Mar;61(3):189-98
pubmed: 17387725
Eur J Intern Med. 2014 Jul;25(6):506-10
pubmed: 24784952
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4424-9
pubmed: 16303929
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6036-42
pubmed: 26393470
Pediatrics. 2000 Mar;105(3 Pt 1):608-14
pubmed: 10699117
Graefes Arch Clin Exp Ophthalmol. 1983;220(1):25-31
pubmed: 6403410
Case Rep Ophthalmol Med. 2013;2013:292981
pubmed: 23710396
Invest Ophthalmol Vis Sci. 2013 Feb 05;54(2):1034-8
pubmed: 23329671
J Med Genet. 2012 Aug;49(8):483-9
pubmed: 22889851
Clin Exp Ophthalmol. 2021 Jul;49(5):516-519
pubmed: 33893699
Clin Genet. 2017 Apr;91(4):529-535
pubmed: 27716896
Hum Genet. 1990 Jan;84(2):116-8
pubmed: 2105266
J Pediatr Ophthalmol Strabismus. 2014 Jul 1;51(4):204-8
pubmed: 24844395
Genet Med. 2021 Aug;23(8):1506-1513
pubmed: 34012067
Hum Mutat. 2013 Nov;34(11):1510-8
pubmed: 23913538
Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):980-4
pubmed: 15891894
Lancet. 2000 Sep 16;356(9234):988-92
pubmed: 11041400
Clin Ophthalmol. 2014;8:165-8
pubmed: 24403820
Arch Ophthalmol. 1965 May;73:696-9
pubmed: 14281990
Ophthalmologica. 1998;212(2):99-104
pubmed: 9486548
J Med Genet. 2007 Feb;44(2):81-8
pubmed: 17105749
Arch Ophthalmol. 1982 Dec;100(12):1939-41
pubmed: 6816197
Invest Ophthalmol Vis Sci. 2012 Dec 03;53(13):7961-6
pubmed: 23150611